Pfiz­er and BioN­Tech roll out new da­ta for their bi­va­lent boost­er against new­er Omi­cron vari­ants

As Pfiz­er and BioN­Tech tout the ef­fec­tive­ness of their bi­va­lent boost­er against Omi­cron vari­ants such as BA.4 and BA.5, more Covid-19 vari­ants have been creep­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA